MYD88 and allergic rhinitis: A recent research found that miR-224-5p overexpression has the potential to inhibit the TLR4/MyD88/NF-κB pathway, thus reducing the ovalbumin-induced allergic rhinitis-associated inflammatory response and thereby limiting allergic rhinitis [14].